KRAS and lung adenocarcinoma: It was of interest to screen the expression of PD-L1 in different lung adenocarcinoma cell lines with wildtype KRAS (H1975, H1650 and H1299) and cell lines harboring KRAS mutations (A549, H460 and A427).